Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity. - Lee W; Kim DK; Synn CB; Lee HK; Park S; Jung DS; Choi Y; Kim JH; Byeon Y; Kim YS; Lee S; Joo Y; et al. (Frontiers in oncology, 2022)